Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors

• Status: Completed
• Trial end date: 2011-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine the subjective response of iron substitution (Tardyferon®) on fatigue in women blood donors with a mean serum ferritin < 30ng/ml and to assess variation of ferritin and hemoglobin after a blood donation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Lausanne
• Collaborator: Pierre Fabre Laboratories
• Treatments: Iron

Criteria

Inclusion Criteria:

• women

• aged 18 - 50

• eligible for a blood donation

Exclusion Criteria:

• men

• age below 18 or above 50

• not eligible for a blood donation (according to the blood donation eligibility guidelines of the Swiss Red Cross)

• hemochromatosis, psychiatric / thyroid / hepatic / rheumatismal / kidney or cardiopulmonary diseases that can cause fatigue

• intestinal disease or medical treatment that can perturb iron absorption and/or excretion

• donors with mental disorder or psychiatric disease that are unable to give consent

• acute or chronic inflammation

• diabetes and pregnancy